Bronchial balsam bells

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT BRONCHIAL BALSAM BELL’S

Composition:

Active substances: menthol (levomenthol), anise oil, tincture of pepper;

5 ml of solution contain: menthol (levomenthol) 1.0 mg; anise oil 0.0035 ml; tincture of pepper 0.025 ml;

Excipients: ginger oil, clove oil, peppermint oil, glycerin, glucose solution, sucrose, tragacanth, benzoic acid (E 210), caramel (E 150), tincture of benzoin, tolu balsam, ethanol 90%, purified water.

Pharmaceutical form. Oral solution.

Main physicochemical properties: dark brown syrup with the odor of ethanol and menthol.

Pharmacotherapeutic group. Medicinal products used in cough and colds. ATC code R05X.

Pharmacological properties.

A combined herbal preparation used for respiratory tract infections associated with colds. The drug exhibits mucolytic, bronchodilatory, expectorant, anti-inflammatory, sedative, and diaphoretic effects.

Menthol provides spasmolytic, antiseptic, and local anesthetic actions, and promotes clearance of mucus from the airways. Anise oil has expectorant, spasmolytic, and antibacterial properties. Pepper tincture exerts a counterirritant effect.

Clinical characteristics.

Indications.

Symptomatic treatment of infectious-inflammatory diseases of the respiratory tract accompanied by sore throat, cough, rhinitis, and inflammation of mucous membranes.

Contraindications.

Hypersensitivity to the components of the drug.

Special precautions.

Use with caution in patients with diabetes mellitus, as the drug contains sucrose and glucose. Do not use in patients with fructose intolerance, glucose-galactose malabsorption, or sucrose-isomaltase deficiency.

Interaction with other medicinal products and other forms of interaction.

Interaction not described.

Special precautions for use.

Use during pregnancy or breastfeeding.

The drug may be used during pregnancy or breastfeeding after a physician has assessed the benefit-risk ratio.

Ability to influence reaction rate when driving or operating machinery.

The drug does not have a sedative effect and does not affect the ability to drive or operate machinery.

Dosage and Administration.

For oral use.

Adults and children aged 12 years and older – 2 teaspoons (10 ml) every hour or 3 teaspoons (15 ml) every 2–3 hours.

Children aged 6–12 years – 1 teaspoon (5 ml) every hour or 2 teaspoons (10 ml) every 2–3 hours.

Children aged 3–6 years – 1 teaspoon (5 ml) every 2 hours.

Shake the bottle before use.

Do not exceed 6 doses within 24 hours. The treatment course lasts 14 days.

Elderly patients should be given the same doses as adults.

Children.

Contraindicated in children under 3 years of age.

Overdose.

Cases of overdose have not been reported.

Side effects.

Gastrointestinal disorders and hypersensitivity reactions, including skin rash and itching, may occur in individuals with individual intolerance to any component of the drug.

Shelf life. 3 years.

Storage conditions.

Store in a place inaccessible to children, at a temperature not exceeding 25 °C.

Packaging.

100 ml or 200 ml in a bottle; 1 bottle in a cardboard box.

Supply classification.

Over-the-counter.

Manufacturer.

Bell Sons & Company (Druggists) Limited.

Bell Sons & Company (Druggists) Limited.

Manufacturer's name and address of the place of business.

Gifford House, Slaidburn Crescent, Southport, PR9 9AL, United Kingdom.

Gifford House, Slaidburn Crescent, Southport, PR9 9AL, United Kingdom.